Supply Chain

Cambridge, Mass.-based Sarepta Therapeutics earned tentative approval from the Food and Drug Administration for its Duchenne's muscular dystrophy drug eteplirsen, according to The New York Times.

A recent report from the Government Accountability Office found that while Medicare Part D generic drug prices decreased overall from 2010 to 2015, many showed exorbitant price hikes.

Joe Kaeser, CEO of Germany-based Siemens, believes geopolitical turbulence may prevent customers from spending money on projects, limiting the amount of orders and revenue the engineering company brings in, reported Bloomberg.

Abbott Laboratories will divest its eye care division to Johnson & Johnson for about $4.33 billion in cash, reported Reuters.

Jimmy Kimmel cracked a joke during the 2016 Emmy Awards about a topic few are smiling about: high drug prices.

Valeant Phramaceuticals is defending its drug discount program for two expensive heart drugs against reports that hospitals are not seeing any savings. The Canadian drugmaker said the program will cover more than 90 percent of the costs for U.S. hospitals,…

The Food and Drug Administration approved Bayer's hormonal contraceptive device Kyleena, reported Reuters.

Medeon Biodesign recently earned Food and Drug Administration approval for AbClose, a port site closure device.

Here are the six latest medical devices or drugs approved by the U.S. Food and Drug Administration.

Six Massachusetts hospitals are participating in a $3.6 million equity funding round to support Blue.Point, an Andover, Mass.-based healthcare startup company, according to the Boston Business Journal.